No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
396 |
4. Check minimum number of eventsNone |
396 |
5. Include endpointsNone |
396 |
6. Filter based on genotype QC (FinnGen only) |
396 |
Control definitions (FinnGen only)
- Control exclude
- K11_ORAL
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Disease of hard tissues of teeth, NOS
based on the number of shared cases.
Similar with more cases:
- Other diseases of hard tissues of teeth
- Diseases of oral cavity, salivary glands and jaws
- Gastrointestinal diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1080 | 609 | 461 |
| Only index persons | 999 | 573 | 426 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 45.31 | 46.73 | 43.69 |
| Only index persons | 44.53 | 45.88 | 42.72 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 396 | 245 | 151 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.07 |
| Median age at first event (years) | 57.74 | 58.15 | 57.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 240
- Matched controls
- 2400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K03.80
ICD-10 Finland
Irradiated enamel
38.8
71.3
91
37
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
+∞
65.7
60
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
21.8
58.9
90
64
K05.30
ICD-10 Finland
Periodontitis complex
+∞
52.0
48
*
SAA03
NOMESCO Finland
Extended examination of mouth
8.5
50.6
154
416
EB1AA
NOMESCO Finland
Tooth X-ray examination
8.5
47.3
191
755
SBB10
NOMESCO Finland
Teeth copy
34.4
43.1
56
21
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
7.0
41.1
137
385
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.0
40.8
134
368
SAA01
NOMESCO Finland
Simple examination of mouth
9.7
39.9
215
1126
K03.88
ICD-10 Finland
Other specified diseases of hard tissues of teeth
49.9
37.8
45
11
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
72.2
37.5
42
7
K03.00
ICD-10 Finland
Approximal wear
81.8
37.3
41
6
K05.31
ICD-10 Finland
Periodontitis pronounced
+∞
36.4
34
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
5.8
34.3
176
775
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
5.9
34.2
184
854
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
5.9
33.5
123
364
SAA04
NOMESCO Finland
Special inverstigation of mouth
40.8
33.1
41
12
K02.1
ICD-10 Finland
Caries of dentine
5.6
32.9
177
802
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
5.2
31.7
147
555
SAA02
NOMESCO Finland
Basic examination of mouth
5.6
31.0
188
943
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
12.8
30.8
57
57
K04.5
ICD-10 Finland
Chronic apical periodontitis
6.3
29.5
92
215
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
14.4
29.4
51
44
WX110
NOMESCO Finland
Local anesthesy
5.8
29.0
201
1124
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
4.7
27.7
137
529
K03.9
ICD-10 Finland
Disease of hard tissues of teeth, unspecified
105.2
26.3
28
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
6.4
26.2
78
168
K07.60
ICD-10 Finland
Snapping jaw
24.0
26.1
37
18
WX290
NOMESCO Finland
Other blockade of nerve
4.4
25.6
145
621
WZB00
NOMESCO Finland
Telephone receipt or other advice
4.9
25.1
102
314
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
4.1
23.9
144
639
K03.66
ICD-10 Finland
Tooth plaque
17.1
23.9
38
26
EBA10
NOMESCO Finland
Surgical removal of tooth
9.1
23.6
52
71
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
13.2
23.5
42
38
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
26.1
23.3
32
14
SDA02
NOMESCO Finland
Parodonthologic therapy
4.4
22.9
104
352
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
9.1
22.9
50
67
K02.0
ICD-10 Finland
Caries limited to enamel
7.1
22.9
60
107
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
48.3
21.9
26
6
EBA00
NOMESCO Finland
Extraction of tooth
4.2
21.1
101
353
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
6.8
20.4
55
101
R4110
NOMESCO Finland
Physiotherapy
4.0
20.2
101
365
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
114.5
19.9
21
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
17.8
19.4
30
19
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
4.0
19.4
96
339
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
6.8
19.3
51
91
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
6.4
18.9
53
102
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
11.5
18.1
34
34
WZA90
NOMESCO Finland
Other doctors statement
4.6
18.1
70
195
K03.64
ICD-10 Finland
Dental calculus supragingival
3.9
17.8
87
302
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
4.0
17.7
86
296
KMAK
NOMESCO Finland
NA
3.3
17.4
146
767
SGC00
NOMESCO Finland
Local medication of root channels of tooth
6.3
17.3
48
91
F45.8
ICD-10 Finland
Other somatoform disorders
7.9
17.1
40
59
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
7.8
16.9
40
60
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
19.8
16.9
25
14
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
6.2
16.7
47
90
SFA40
NOMESCO Finland
Replacement of krone of tooth
4.4
16.7
68
198
K04.1
ICD-10 Finland
Necrosis of pulp
6.6
16.4
44
79
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.3
16.2
45
85
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
4.8
15.9
58
150
-1
NOMESCO Finland
NA
3.4
15.8
99
412
K05.3
ICD-10 Finland
Chronic periodontitis
+∞
15.8
15
*
K05.1
ICD-10 Finland
Chronic gingivitis
+∞
15.8
15
*
K08.80
ICD-10 Finland
Toothache NOS
7.3
15.5
38
60
SDA01
NOMESCO Finland
Simple parodonthologic therapy
3.9
15.5
74
247
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
7.5
15.4
37
57
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
5.2
15.3
50
115
K10.3
ICD-10 Finland
Alveolitis of jaws
10.7
14.1
27
28
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
56.8
14.0
16
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
+∞
13.7
13
*
Z01.2
ICD-10 Finland
Dental examination
2.9
13.6
111
542
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
3.4
13.4
76
288
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
13.3
115
579
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.8
13.2
132
729
M79.6
ICD-10 Finland
Pain in limb
3.0
13.1
102
478
N03AX16
ATC
pregabalin; oral
3.4
13.1
73
271
K05.18
ICD-10 Finland
Chronic gingivitis
+∞
12.6
12
*
SFA00
NOMESCO Finland
Small filling
4.7
12.5
44
109
N02AX02
ATC
tramadol; systemic, rectal
2.8
12.5
114
588
ZXA05
NOMESCO Finland
Left side
3.2
12.4
77
309
SBA00
NOMESCO Finland
Microbiological examinations
39.8
12.4
15
*
N02BE01
ATC
paracetamol; systemic, rectal
3.8
12.1
214
1647
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
7.6
12.0
28
41
XF400
NOMESCO Finland
ECG with 12 standard connections
4.0
11.8
51
153
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
31.8
11.8
15
5
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
3.4
11.7
64
233
K05.32
ICD-10 Finland
Periodontitis NOS
+∞
11.5
11
*
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
+∞
11.5
11
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.4
11.5
30
52
WX002
NOMESCO Finland
Sedation and analgesia
3.5
11.4
57
194
R52.2
ICD-10 Finland
Other chronic pain
13.6
11.3
19
15
K04.08
ICD-10 Finland
Other specified pulpit
6.6
11.3
29
49
SGA01
NOMESCO Finland
Tooth opening as first aid
3.6
11.0
54
180
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.0
11.0
73
302
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.9
11.0
27
43
H04.10
ICD-10 Finland
Dry eye syndrome
4.9
10.8
36
84
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
10.8
66
259
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.6
10.7
51
166
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
10.7
63
241
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
10.6
77
339
EMAK
NOMESCO Finland
NA
12.9
10.5
18
15
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
9.5
10.5
21
24
K05.08
ICD-10 Finland
Another acute gingivitis
+∞
10.5
10
*
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
10.7
10.2
19
19
SXC05
NOMESCO Finland
Other oral or dental procedure
7.3
10.2
24
36
EBB10
NOMESCO Finland
Insertion of dental implant
41.9
10.1
12
*
127
Kela drug reimbursment
Transplant complication
27.3
9.9
13
5
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.8
9.7
32
74
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
18.5
9.5
14
8
K04.00
ICD-10 Finland
Hyperemia of pulp
9.3
9.5
19
22
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
103.9
9.5
10
*
N03AX12
ATC
gabapentin; oral
3.4
9.5
49
170
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
+∞
9.4
9
*
K05.39
ICD-10 Finland
Periodontitis UNS
+∞
9.4
9
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
7.2
9.4
22
33
K08.3
ICD-10 Finland
Retained dental root
6.4
9.3
24
41
M79.1
ICD-10 Finland
Myalgia
3.6
9.2
43
138
P01AB01
ATC
metronidazole; oral, rectal
2.4
9.0
107
606
A02BC02
ATC
pantoprazole; systemic
2.3
9.0
158
1082
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.9
8.9
29
66
G44.2
ICD-10 Finland
Tension-type headache
3.4
8.9
44
147
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.7
8.9
30
71
J01FF01
ATC
clindamycin; systemic
2.6
8.8
77
372
ZX120
NOMESCO Finland
Intravenous
4.2
8.8
33
87
SPB10
NOMESCO Finland
Production of temporary crone to tooth
51.9
8.7
10
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
8.7
67
300
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
17.1
8.6
13
8
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
3.5
8.6
41
133
J01DB01
ATC
cefalexin; oral
2.7
8.6
203
1598
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
93.2
8.5
9
*
K03.0
ICD-10 Finland
Excessive attrition of teeth
93.2
8.5
9
*
K03.1
ICD-10 Finland
Abrasion of teeth
93.2
8.5
9
*
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
4.7
8.5
28
65
R07.4
ICD-10 Finland
Chest pain, unspecified
2.7
8.4
67
304
K05.0
ICD-10 Finland
Acute gingivitis
+∞
8.4
8
*
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
15.2
8.3
13
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
8.2
93
509
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
8.1
61
268
Z94.0
ICD-10 Finland
Kidney transplant status
22.9
8.1
11
5
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.5
8.0
28
69
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
8.0
49
191
N05BA01
ATC
diazepam; systemic, rectal
3.2
7.8
41
143
SPC01
NOMESCO Finland
Fixed dental crown
46.5
7.8
9
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.1
7.7
20
35
Z01.7
ICD-10 Finland
Laboratory examination
3.5
7.7
35
110
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
7.6
38
128
H10
ICD-10 Finland
Conjunctivitis
5.1
7.6
23
49
S18
ICPC
Laceration/cut
2.2
7.6
99
578
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.4
7.6
36
117
D20
ICPC
Mouth/tongue/lip symptom/complaint
6.4
7.6
19
32
K04.0
ICD-10 Finland
Pulpitis
3.6
7.5
34
106
A02BC05
ATC
esomeprazole; systemic
2.2
7.5
100
587
ECA20
NOMESCO Finland
Biopsy of gingiva
82.5
7.5
8
*
K03.09
ICD-10 Finland
Abrasion of the teeth UNS
82.5
7.5
8
*
SXC03
NOMESCO Finland
Other oral or dental procedure
82.5
7.5
8
*
R4190
NOMESCO Finland
Nutritional therapy
6.6
7.4
18
29
K11.70
ICD-10 Finland
Hypoptyalism
+∞
7.3
7
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
+∞
7.3
7
*
K05.09
ICD-10 Finland
Acute gingivitis, UNS
+∞
7.3
7
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
+∞
7.3
7
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
16.4
7.3
11
7
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
20.8
7.2
10
5
L82
ICD-10 Finland
Seborrhoeic keratosis
3.2
7.1
39
138
L04AX01
ATC
azathioprine; systemic
5.5
7.1
20
39
A04
ICPC
Weakness/tiredness general
3.3
7.1
36
123
R50.9
ICD-10 Finland
Fever, unspecified
3.2
7.1
37
129
R51.80
ICD-10 Finland
Headache
2.9
7.1
45
179
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
7.1
72
369
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
7.1
76
402
K02.8
ICD-10 Finland
Other dental caries
14.3
7.0
11
8
A02BC03
ATC
lansoprazole; oral
2.3
6.9
73
381
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
6.9
33
108
L04AD01
ATC
ciclosporin; systemic
11.4
6.9
12
11
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
6.8
29
86
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
41.2
6.8
8
*
SXA20
NOMESCO Finland
Local application of medicine to mouth
4.9
6.8
21
46
R06.0
ICD-10 Finland
Dyspnoea
2.5
6.8
58
272
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
6.7
29
87
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.2
6.7
17
29
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.6
6.7
22
51
Z71.8
ICD-10 Finland
Other specified counselling
2.3
6.7
67
341
K03.29
ICD-10 Finland
Erosion of teeth occupational
23.3
6.7
9
*
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
4.3
6.7
24
61
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
6.7
29
88
X58
ICD-10 Finland
Exposure to other specified factors
2.9
6.7
42
166
R52.0
ICD-10 Finland
Acute pain
7.2
6.6
15
22
J01CE02
ATC
phenoxymethylpenicillin; oral
2.1
6.6
174
1327
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
6.6
28
83
TK800
NOMESCO Finland
Hemodialysis
10.4
6.6
12
12
K04.09
ICD-10 Finland
Pulpit UNS
6.5
6.6
16
26
J05AB01
ATC
aciclovir; systemic
2.5
6.6
57
269
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
4.3
6.5
23
58
M03BX02
ATC
tizanidine; oral
2.0
6.5
152
1105
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
71.6
6.5
7
*
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
71.6
6.5
7
*
R52.9
ICD-10 Finland
Pain, unspecified
3.8
6.4
26
74
J01MA02
ATC
ciprofloxacin; systemic
2.1
6.4
90
529
R13
ICD-10 Finland
Dysphagia
5.1
6.4
19
40
N06AX11
ATC
mirtazapine; oral
2.1
6.4
82
467
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
6.4
112
727
M25.5
ICD-10 Finland
Pain in joint
2.2
6.3
75
411
G50.1
ICD-10 Finland
Atypical facial pain
18.6
6.3
9
5
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
18.6
6.3
9
5
K07.4
ICD-10 Finland
Malocclusion, unspecified
18.6
6.3
9
5
A12AA04
ATC
calcium carbonate; oral
18.6
6.3
9
5
UJF32
NOMESCO Finland
Coloscopy
2.4
6.3
58
283
N03AE01
ATC
clonazepam; systemic
4.3
6.3
22
55
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
+∞
6.3
6
*
EB1WA
NOMESCO Finland
NA
+∞
6.3
6
*
SAAPA
NOMESCO Finland
NA
+∞
6.3
6
*
SPA50
NOMESCO Finland
Determination of bite and dental arch location
+∞
6.3
6
*
K05.22
ICD-10 Finland
Acute pericoronitis
+∞
6.3
6
*
ECA55
NOMESCO Finland
Complicated parodontal operation
+∞
6.3
6
*
K03.18
ICD-10 Finland
Other abrasion of the teeth
+∞
6.3
6
*
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
27.5
6.3
8
*
B03XA01
ATC
erythropoietin; parenteral
27.5
6.3
8
*
137
Kela drug reimbursment
Uraemia requiring dialysis
27.5
6.3
8
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
6.3
115
755
N05CF01
ATC
zopiclone; oral
2.2
6.3
76
419
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.3
6.2
30
99
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.0
6.2
13
17
WX110
SPAT
NA
5.5
6.1
17
33
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
6.1
25
72
F39
ICD-10 Finland
Unspecified mood [affective] disorder
13.0
6.1
10
8
P01
ICPC
Feeling anxious/nervous/tense
3.1
6.1
32
112
ZXA00
NOMESCO Finland
Right side
2.3
6.1
61
309
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
5.8
6.1
16
29
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.0
6.1
18
38
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
6.0
62
316
N05AH04
ATC
quetiapine; oral
2.6
6.0
44
189
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
130
404
4.30
37.97
5.0
2.7
e6/l
3.8
2.3
0.86
86
215
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
211
1017
3.30
30.29
4.1
2.7
u/l
30.4
32.6
0.44
195
971
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
214
1045
3.28
29.96
2.6
1.8
pmol/l
92.6
95.6
0.43
115
515
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
51
8.61
29.92
7.8
3.6
iu/ml
5857.2
310.0
—
5
5
(42870588) Differential panel, method unspecified - Blood
198
953
3.16
27.90
10.3
5.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
131
496
3.45
27.59
5.5
3.2
ng/l
454.5
464.3
0.01
100
345
(3024561) Albumin [Mass/volume] in Serum or Plasma
221
1156
3.06
26.49
11.4
4.0
g/l
35.8
36.1
0.44
212
1091
(3022096) Basophils/100 leukocytes in Blood
246
1372
3.09
26.15
10.0
5.2
%
0.7
0.7
0.37
238
1285
(40758558) Short blood count panel - Blood
162
736
3.03
24.63
10.4
6.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
247
1422
2.96
24.04
10.3
5.2
%
2.7
2.9
0.72
240
1333
(3019069) Monocytes/100 leukocytes in Blood
247
1429
2.94
23.69
10.6
5.4
%
8.9
8.5
1.42
240
1349
(3042936) Bacteria identified in Isolate by Culture
105
378
3.42
23.57
2.6
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
192
976
2.88
23.48
7.8
3.2
e6/l
41.1
101.2
0.93
138
684
(3023368) Bacteria identified in Blood by Culture
149
664
2.99
23.21
6.4
3.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
91
305
3.58
22.78
3.9
2.4
umol/l
7.5
6.7
0.16
79
265
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
232
1321
2.83
22.55
16.1
5.8
mmol/l
1.2
1.2
0.36
217
1097
(3018010) Neutrophils/100 leukocytes in Blood
247
1462
2.83
22.11
10.3
5.1
%
55.9
57.0
0.70
241
1381
(3000494) Fungus identified in Specimen by Culture
94
330
3.42
21.83
2.3
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
248
1478
2.81
21.78
10.4
5.2
%
29.7
28.3
1.11
241
1389
(3013115) Eosinophils [#/volume] in Blood
257
1567
2.82
21.47
11.0
5.7
e9/l
0.2
0.2
0.50
239
1396
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
329
2303
3.53
21.17
14.4
6.8
u/l
80.6
77.8
0.42
324
2166
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
212
1179
2.72
21.16
12.8
5.1
mmol/l
1.2
1.2
0.34
202
1076
(3002582) Erythrocytes [#/volume] in Urine
165
816
2.75
20.69
5.8
2.7
e6/l
28.3
111.5
0.52
124
622
(3001604) Monocytes [#/volume] in Blood
248
1507
2.73
20.47
10.2
5.3
e9/l
0.6
0.6
1.14
229
1323
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
53
130
4.55
20.35
2.2
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
141
648
2.83
20.31
2.5
2.0
mg/l
2.4
3.0
1.98
119
552
(3006315) Basophils [#/volume] in Blood
248
1513
2.71
20.21
10.3
5.3
e9/l
0.0
0.0
0.50
229
1332
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
34
56
6.55
20.18
1.8
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
109
438
3.05
20.05
4.9
2.5
e6/l
0.9
0.8
0.00
65
248
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
62
176
3.99
19.63
2.0
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
108
438
3.02
19.49
6.5
2.8
mmol/l
0.8
0.8
0.35
100
417
(3021960) Folate [Moles/volume] in Serum or Plasma
128
571
2.83
19.38
1.8
1.4
nmol/l
21.3
22.0
0.21
116
485
(3026782) Osmolality of Urine
121
524
2.89
19.37
4.4
2.3
mosm/kgh2o
535.0
553.5
0.38
103
442
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
59
6.21
19.17
1.8
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
42
89
5.16
19.17
1.5
2.0
g/l
1.4
1.4
0.19
33
77
(3015377) Calcium [Moles/volume] in Serum or Plasma
175
925
2.60
18.80
6.9
3.1
mmol/l
2.3
2.4
1.23
146
829
(3044640) Blood type and Crossmatch panel - Blood
177
947
2.57
18.46
3.6
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
248
1556
2.59
18.39
10.4
5.3
e9/l
2.0
1.9
0.19
231
1396
(3013650) Neutrophils [#/volume] in Blood by Automated count
271
1775
2.67
18.35
17.4
8.2
e9/l
3.6
4.0
2.44
249
1572
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
370
3.06
18.31
4.1
2.1
g/l
2.4
2.4
0.15
89
344
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
72
240
3.44
17.93
2.8
2.3
g/l
0.2
0.2
1.37
66
228
(3007853) Bacteria identified in Skin by Aerobe culture
87
326
3.14
17.89
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
179
984
2.49
17.36
5.8
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
205
1204
2.46
17.13
3.5
2.1
nmol/l
73.8
75.7
0.46
192
1106
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
276
3.22
17.01
2.9
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
343
3.01
16.83
4.4
2.0
%
21.4
23.6
0.73
71
299
(3017143) Hepatitis C virus Ab [Presence] in Serum
93
382
2.87
16.13
2.3
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
72
257
3.20
15.97
3.3
2.4
%
1.8
1.7
0.13
65
233
(3026008) Bacteria identified in Urine by Culture
149
778
2.47
15.87
3.9
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
182
1042
2.38
15.74
12.3
7.3
inr
1.2
1.2
0.27
33
331
(3022948) Iron [Moles/volume] in Serum or Plasma
95
400
2.81
15.69
4.3
2.0
umol/l
13.6
13.7
0.03
88
373
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
135
677
2.51
15.66
4.0
1.7
mg/l
0.9
1.1
1.11
95
531
(3007164) IgA [Mass/volume] in Serum or Plasma
130
642
2.53
15.57
2.0
1.4
g/l
2.3
2.4
0.13
81
434
(3012544) pH of Venous blood
65
223
3.29
15.36
10.5
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
161
884
2.38
15.20
3.8
2.3
u/l
54.8
57.1
0.39
152
820
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
17
10.40
15.01
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
142
741
2.43
15.00
5.7
2.7
e6/l
0.4
0.5
0.16
106
548
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
74
279
3.03
14.90
3.0
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
149
797
2.39
14.87
5.0
2.2
umol/l
2313.2
8429.6
1.53
137
711
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
93
398
2.75
14.82
2.8
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
218
1373
2.31
14.82
4.3
2.6
ug/l
116.1
102.9
0.42
211
1277
(3002032) Base excess in Venous blood by calculation
62
215
3.23
14.36
11.0
2.9
mmol/l
1.1
2.4
2.97
55
181
(3013707) Erythrocyte sedimentation rate by Westergren method
308
2270
2.61
14.36
5.7
3.5
mm/h
13.9
10.6
3.00
294
2116
(40768804) Tissue Pathology biopsy report
198
1226
2.23
13.68
2.7
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
60
5.14
13.54
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
92
409
2.63
13.50
1.7
1.6
nmol/l
911.3
1266.9
4.31
68
316
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
382
3229
6.18
13.03
28.7
10.8
mg/l
23.2
21.5
0.43
329
2445
(3037467) Urinalysis macro (dipstick) panel - Urine
286
2086
2.34
12.85
7.8
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
302
2255
2.43
12.84
4.3
2.8
u/l
59.4
46.3
1.10
293
2121
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
391
3524
9.67
12.52
18.8
8.7
u/l
28.1
27.3
0.42
384
3406
(3022217) INR in Platelet poor plasma by Coagulation assay
69
277
2.81
12.29
17.4
16.0
inr
1.1
1.3
—
5
48
(3044889) 12 lead EKG panel
291
2161
2.31
12.16
4.6
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
90
415
2.51
12.14
2.3
1.6
%
1.4
1.4
0.18
76
369
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
58
4.92
12.07
1.4
1.2
u/ml
377.0
236.7
0.88
17
32
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
315
2427
2.46
11.96
4.8
3.9
pmol/l
14.3
14.7
2.25
296
2233
(36304419) Bacteria [Presence] in Urine
134
744
2.21
11.76
5.8
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
63
248
2.83
11.61
1.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
105
3.78
11.60
1.5
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
381
3269
5.37
11.48
30.9
12.0
mmol/l
139.4
139.7
2.15
375
3179
(3021589) Normoblasts [#/volume] in Blood
210
1399
2.07
11.30
12.9
8.1
e9/l
0.0
0.0
0.32
174
1154
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
54
4.87
11.10
1.6
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
54
4.87
11.10
1.6
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
381
3285
5.22
11.03
31.5
12.1
mmol/l
3.9
4.0
0.47
375
3188
(3028026) IgM [Mass/volume] in Serum or Plasma
53
195
2.98
11.02
2.1
1.5
g/l
1.0
1.4
1.08
47
182
(3024928) Oxygen saturation in Venous blood
22
43
5.36
10.91
8.8
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
33
91
3.87
10.76
2.2
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
89
431
2.37
10.69
1.4
1.3
titre
525.3
466.3
0.12
15
76
(3000991) Gas panel - Venous blood
51
189
2.95
10.46
22.3
8.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
121
672
2.15
10.42
2.4
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
70
4.23
10.41
3.3
3.2
u/ml
0.3
0.4
—
8
35
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
41
135
3.27
10.26
16.8
9.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
122
684
2.13
10.23
5.0
3.0
ng/l
649.1
935.1
1.24
111
568
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
364
3080
3.25
10.18
22.5
10.1
ml/min/173m2
85.4
85.6
0.05
305
2538
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
126
720
2.10
10.02
3.5
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
91
457
2.29
10.00
4.0
2.6
mmol/l
2.4
2.4
0.33
80
413
(3048689) Calprotectin [Mass/mass] in Stool
80
381
2.38
9.92
2.8
2.2
ug/g
246.6
118.2
0.78
61
306
(3007461) Platelets [#/volume] in Blood
396
3724
+∞
9.88
39.9
16.1
e9/l
252.5
254.2
0.22
389
3647
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
137
812
2.05
9.85
2.5
2.0
u/l
193.6
180.6
0.09
130
756
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
351
2927
2.75
9.84
6.3
4.5
mu/l
1.9
1.8
0.09
336
2707
(3023520) Reticulocytes [#/volume] in Blood
49
184
2.90
9.81
2.9
2.7
e9/l
68.2
70.9
0.15
33
136
(3035637) Corticotropin [Mass/volume] in Plasma
15
22
7.05
9.80
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
396
3728
+∞
9.69
39.9
16.1
e12/l
4.4
4.6
6.48
389
3644
(3000850) Epithelial cells [#/volume] in Urine
104
559
2.17
9.65
3.3
2.2
e6/l
4.9
6.6
0.47
82
488
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
186
2.87
9.61
9.5
3.1
ng/l
127.9
71.4
1.91
43
163
(3000963) Hemoglobin [Mass/volume] in Blood
396
3729
+∞
9.46
40.1
16.1
g/l
132.7
136.9
7.00
391
3686
(3010813) Leukocytes [#/volume] in Blood
396
3729
+∞
9.46
40.0
16.1
e9/l
6.9
6.5
0.73
389
3647
(3003396) Base excess in Arterial blood by calculation
62
269
2.55
9.38
13.8
8.0
mmol/l
0.6
1.2
0.84
56
219
(3009261) Glucose [Presence] in Urine by Test strip
216
1519
1.93
9.30
4.3
3.1
estimate
0.0
0.0
0.00
25
272
(3021601) Nitrite [Presence] in Urine by Test strip
215
1512
1.92
9.24
6.8
4.3
estimate
0.0
0.0
0.50
23
287
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
364
3118
3.07
9.19
5.2
4.0
mmol/l
5.9
5.8
0.19
347
2876
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
642
2.06
8.99
3.8
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
134
810
1.99
8.97
8.5
3.5
ph
7.4
7.4
—
8
166
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
349
2943
2.57
8.81
7.1
4.9
mmol/mol
38.5
39.2
0.88
334
2762
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
32
5.51
8.76
1.4
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
81
3.64
8.53
6.3
1.6
g/l
7.8
7.5
0.26
17
69
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
77
3.69
8.40
1.4
1.4
ug/g
332.2
309.7
0.19
16
46
(3000475) Leukocytes [#/volume] in Synovial fluid
22
54
4.25
8.37
1.8
1.6
e6/l
6448.5
12354.7
0.85
15
40
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
111
644
2.01
8.25
1.8
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
209
1492
1.85
8.23
4.3
3.1
estimate
0.0
0.0
0.00
19
282
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
206
1468
1.84
8.12
5.7
3.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
32
106
3.20
7.93
6.5
4.6
%
1.7
1.7
0.08
32
101
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
545
2.03
7.85
1.4
1.2
iu/ml
27.1
35.8
0.29
31
176
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
81
3.50
7.81
6.4
1.6
g/l
3.5
3.8
0.60
15
65
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
81
3.50
7.81
6.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
557
2.01
7.66
2.3
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
6
18.80
7.64
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
11
6
18.80
7.64
1.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
78
3.50
7.52
6.7
1.6
g/l
3.5
3.0
0.90
16
67
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
22
6.08
7.42
2.5
3.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
31
106
3.09
7.30
6.7
4.7
%
0.9
0.9
0.37
31
101
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
101
3.13
7.25
1.8
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
38
4.63
7.25
2.7
2.6
—
—
—
0
0
(3036489) Thrombin time
31
107
3.06
7.18
3.2
1.9
s
21.2
21.3
0.02
25
96
(4035726)
55
255
2.34
7.16
1.5
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
5
20.46
7.16
1.1
1.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
28
91
3.23
7.16
3.4
2.1
g/l
3.9
3.9
0.04
28
84
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
61
3.76
7.13
1.5
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
74
391
2.10
7.01
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
383
3470
4.16
6.97
24.2
10.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
51
232
2.38
6.93
15.9
8.7
g/l
115.4
122.8
1.62
51
225
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
117
729
1.86
6.88
1.5
1.3
u/ml
1.0
2.7
1.14
28
197
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
75
3.34
6.53
6.8
1.6
g/l
10.2
10.6
0.18
17
69
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
7
14.61
6.43
1.1
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
68
360
2.07
6.38
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
22
5.59
6.32
2.8
2.2
e9/l
1.0
1.0
—
7
11
(3021788) Differential panel - Synovial fluid
15
34
4.55
6.29
1.9
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
62
3.52
6.23
1.5
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
51
244
2.25
6.17
15.7
8.4
%
94.6
96.1
0.38
51
238
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
87
509
1.91
6.14
1.3
1.2
u/ml
14.1
5.6
0.58
30
201
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
370
3324
2.72
6.12
5.8
4.4
mmol/l
2.8
2.9
0.74
350
3106
(3023410) Appearance of Cerebral spinal fluid
12
23
5.35
6.04
1.3
1.3
—
—
—
0
0
(3013512) EKG study
122
797
1.77
6.02
4.8
3.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
49
3.80
5.99
1.9
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
16
6.39
5.98
2.8
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
279
2285
1.75
5.94
3.8
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
49
236
2.23
5.83
2.4
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
41
4.02
5.77
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
45
211
2.28
5.71
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
24
82
3.05
5.67
3.9
3.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
17
6.01
5.65
5.0
1.5
%
10.1
11.8
—
10
17
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
124
2.63
5.52
2.6
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
57
3.45
5.51
1.9
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
38
4.06
5.49
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
143
2.51
5.47
1.8
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
267
2.09
5.27
5.0
4.3
ug/l
7.2
7.8
0.05
44
227
(3028707) Methadone [Presence] in Urine by Screen method
16
44
3.75
5.26
1.9
1.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
28
110
2.66
5.17
7.4
2.3
%
1.0
1.2
0.65
28
110
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
40
3.86
5.14
1.1
1.2
u/ml
1.9
2.4
—
7
17
(3009542) Hematocrit [Volume Fraction] of Blood
350
3119
2.05
5.10
35.9
11.5
%
38.9
40.5
3.10
279
2434
(36660697) Celiac disease serology panel - Serum
48
243
2.11
5.05
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
68
393
1.88
4.93
2.2
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
37
3.89
4.85
1.9
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
42
3.67
4.81
1.1
1.2
u/ml
1.1
1.5
—
7
15
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
47
3.51
4.80
1.7
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
85
2.81
4.76
2.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
91
2.74
4.75
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
447
1.81
4.66
2.4
2.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
16
48
3.43
4.65
1.2
1.3
mmol/l
7.1
7.2
0.07
16
32
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
41
202
2.15
4.63
3.4
3.4
pmol/l
4.2
4.6
1.82
36
185
(3010375) cycloSPORINE [Mass/volume] in Blood
7
5
14.21
4.59
52.6
56.6
ug/l
128.3
117.4
—
7
5
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
59
3.15
4.57
1.3
1.3
e6/l
6.4
7.9
—
10
44
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
59
3.15
4.57
1.3
1.4
e6/l
123.5
64.0
—
10
47
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
65
3.02
4.50
1.6
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
30
4.09
4.47
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
28
119
2.46
4.43
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
37
178
2.19
4.43
2.2
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
34
158
2.26
4.42
6.6
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
33
152
2.28
4.38
5.8
4.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
40
3.59
4.37
2.6
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
360
3279
2.08
4.34
5.1
4.0
mmol/l
1.4
1.5
1.60
340
3064
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
43
222
2.05
4.31
2.3
2.3
—
15.4
—
0
11
(3026389) Candida sp identified in Specimen by Organism specific culture
12
31
3.96
4.28
1.7
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
360
3286
2.05
4.20
5.2
4.1
mmol/l
4.7
4.8
1.03
339
3077
(40760888) Immunoglobulin light chains.free panel - Serum
17
57
3.07
4.17
12.7
2.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
23
4.43
4.11
3.6
2.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
7
10.15
4.02
2.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
65
2.85
3.91
1.5
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
54
3.05
3.89
1.3
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
5
12.15
3.77
3.5
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
85
2.55
3.69
2.7
1.7
—
—
—
0
0
(3000492) Spirometry study
55
327
1.79
3.64
2.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
96
663
1.59
3.64
3.3
3.3
kg/l
1.0
1.0
1.31
12
92
(3045414) Leukocytes [Presence] in Urine
26
118
2.29
3.59
2.3
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
87
2.49
3.53
1.2
1.2
—
29.9
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
18
69
2.69
3.52
4.3
3.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
141
1067
1.50
3.52
3.6
2.9
ng/l
34.4
27.6
0.17
81
653
(3017704) Immunofixation for Urine
8
13
6.25
3.51
4.6
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
30
147
2.13
3.46
7.1
6.8
mmol/l
24.5
25.1
0.39
30
139
(3037121) Protein [Mass/volume] in Urine
21
88
2.46
3.45
4.0
3.7
g/l
0.5
0.3
0.45
13
36
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
37
3.31
3.37
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
346
3164
1.74
3.36
4.4
3.7
mmol/l
1.4
1.3
1.29
324
2959
(4010399)
37
201
1.93
3.25
1.9
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
56
347
1.71
3.22
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
55
2.80
3.19
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
61
2.69
3.17
1.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
118
878
1.49
3.14
3.9
3.0
mmol/l
7.3
7.7
0.32
103
740
(4306422)
12
39
3.14
3.11
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
133
2.11
3.09
1.8
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
12
5.92
3.03
1.7
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
12
40
3.06
2.99
1.4
1.2
mmol/l
47.8
62.7
0.95
12
35
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
157
1.99
2.94
1.2
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
136
2.06
2.93
2.3
2.2
u/l
219.3
2434.5
—
9
64
(4268621)
10
30
3.39
2.92
1.7
2.2
—
—
—
0
0
(44790048)
11
36
3.11
2.83
2.0
1.4
—
—
—
0
0
(44790049)
11
36
3.11
2.83
2.0
1.4
—
—
—
0
0
(44806118)
11
36
3.11
2.83
2.0
1.4
—
—
—
0
0
(44790047)
11
36
3.11
2.83
2.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
23
3.98
2.79
4.0
4.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
78
2.37
2.79
2.4
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
85
2.30
2.75
1.9
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
198
1.84
2.74
1.3
1.3
—
39.0
—
0
12
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
19
4.27
2.69
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
148
1.96
2.68
2.4
1.4
iu/l
23.9
24.8
0.05
22
123
(3025941) Bacteria identified in Stool by Culture
31
170
1.89
2.67
1.5
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
142
1.97
2.63
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
80
571
1.50
2.57
1.7
1.7
pmol/l
407.3
57676775.8
1.19
72
482
(3006653) Thiamine [Moles/volume] in Blood
6
11
5.52
2.55
1.2
1.4
nmol/l
109.0
154.7
—
6
11
(3017181) Myelocytes/100 leukocytes in Blood
42
257
1.71
2.55
5.9
3.8
%
1.0
1.0
—
8
77
(3028300) Cannabinoids [Presence] in Urine
27
144
1.94
2.53
1.8
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
144
1.94
2.53
1.8
1.4
—
—
—
0
0
(1002224) Polysomnography panel
28
152
1.91
2.50
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
26
3.52
2.49
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
63
2.44
2.49
1.7
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
117
2.03
2.46
1.1
1.2
—
2.7
—
0
7
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
83
2.22
2.45
1.2
1.2
—
4.6
—
0
5
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
70
2.34
2.44
1.2
1.3
mg/l
467.7
498.8
0.19
16
63
(3020682) Albumin/Creatinine [Ratio] in Urine
111
854
1.42
2.41
4.3
3.9
mg/mmol
28.6
8.1
1.38
73
530
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
104
2.08
2.41
1.9
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
392
1.56
2.39
1.6
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
33
192
1.78
2.38
2.4
2.4
e9/l
4.2
4.1
0.13
28
158
(3019832) Treponema pallidum Ab [Presence] in Serum
57
384
1.57
2.38
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
52
2.55
2.38
1.2
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
8
6.31
2.38
1.8
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
126
1.96
2.36
1.3
1.4
miu/ml
81.9
248.7
—
8
67
(3000764) Benzodiazepines [Presence] in Urine
26
141
1.90
2.34
1.8
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
232
1.71
2.33
6.3
4.0
%
0.0
0.0
—
7
62
(40761536) Microorganisms panel - Urine sediment
12
270
0.43
2.31
2.8
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
53
2.50
2.30
1.2
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
18
3.94
2.26
4.7
4.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
120
948
1.38
2.22
1.5
1.5
—
—
—
0
0
(4198724)
5
9
5.61
2.22
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
42
2.67
2.20
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
24
3.38
2.19
1.8
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
25
3.24
2.10
1.4
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
10
5.05
2.07
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
125
1.89
2.07
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
118
1.92
2.06
5.8
3.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
15
4.04
2.04
2.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
50
2.44
2.04
5.6
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
97
2.01
2.04
2.2
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
38
242
1.63
2.02
6.2
3.9
%
0.1
0.2
—
8
67
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
32
2.85
2.01
1.4
1.5
g/l
1.1
1.0
—
9
32
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
149
1.80
2.00
5.1
3.0
mmol/l
0.6
2.1
0.75
16
121
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
798
1.37
1.98
5.2
4.0
ug/l
2.5
2.0
0.33
94
738
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
21
3.37
1.97
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
11
4.59
1.94
2.8
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
11
4.59
1.94
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
33
2.77
1.94
4.1
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
16
3.79
1.94
1.3
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
85
2.04
1.93
2.6
2.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
58
2.28
1.93
1.7
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
13
58
2.28
1.93
1.1
1.4
mmol/l
4.1
3.7
0.42
13
53
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
22
3.22
1.89
7.1
4.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
59
2.24
1.86
1.9
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
66
2.16
1.84
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
53
2.30
1.82
1.5
1.1
u/ml
2.4
3.3
—
7
23
(3002179) Metamyelocytes/100 leukocytes in Blood
36
234
1.59
1.78
4.7
3.9
%
0.7
0.5
—
7
60
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
18
3.37
1.75
1.3
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
83
641
1.37
1.74
4.8
3.7
%
21.4
21.7
0.04
32
268
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.88
1.72
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
13
3.88
1.72
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
26
157
1.70
1.70
5.4
3.1
—
7.4
—
0
21
(3025130) Human papilloma virus identified in Specimen
10
42
2.42
1.69
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
69
2.07
1.66
1.6
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
69
2.07
1.66
2.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
25
2.83
1.65
3.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
37
247
1.55
1.65
3.8
2.3
nmol/l
12.8
12.6
0.06
32
228
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
106
1.83
1.61
1.2
2.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
32
2.53
1.60
3.1
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
32
2.53
1.60
3.1
2.0
mmol/l
4.0
4.0
—
8
32
(3035285) Chloride [Moles/volume] in Venous blood
8
32
2.53
1.60
3.1
2.0
mmol/l
106.3
105.9
—
8
32
(3045142) Bone marrow Pathology biopsy report
7
26
2.72
1.58
2.1
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
64
2.07
1.56
1.4
1.2
u/ml
0.3
1.6
—
8
23
(3012516) Albumin [Mass/volume] in Urine
100
810
1.31
1.53
5.3
3.1
mg/l
3738.8
216.1
1.56
60
508
(3035933) Granulocytes/100 leukocytes in Blood
5
15
3.36
1.53
1.6
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
21
2.88
1.51
1.8
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
12
58
2.10
1.50
6.3
2.2
kpa
9.0
8.0
0.77
12
53
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
46
2.20
1.41
1.8
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
68
1.94
1.35
2.5
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
10
47
2.16
1.34
2.4
2.4
umol/l
6.1
6.7
—
10
29
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
61
470
1.35
1.31
4.0
2.6
ug/l
0.7
0.8
0.38
45
273
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
69
1.91
1.30
2.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
36
2.25
1.25
1.3
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
14
238
0.57
1.24
3.0
2.9
mmol/l
1.2
1.2
0.14
14
207
(3038515) Glucose [Moles/volume] in Venous blood
11
56
1.99
1.23
5.5
2.4
mmol/l
7.1
7.3
0.15
11
56
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
19
2.65
1.22
1.6
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
71
1.86
1.21
1.7
1.6
—
—
—
0
0
(3019225) pH of Specimen
33
232
1.46
1.20
8.8
3.6
—
—
—
0
0
(4062490)
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
38
2.13
1.19
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
121
1396
0.81
1.16
2.8
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
120
1.61
1.10
5.2
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
21
2.40
1.09
1.8
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
16.4
10.5
mmol/l
0.6
0.6
—
5
21
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
59
1.89
1.08
1.4
1.1
u/ml
1.8
6.0
—
6
18
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
187
1.48
1.07
1.7
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
247
1.41
1.06
1.4
1.2
iu/ml
118.9
143.6
—
10
99
(21494755) Public health laboratory ask at order entry panel
32
435
0.71
1.05
1.6
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
22
2.29
1.03
7.2
2.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
1.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
2.3
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
7
35
2.02
1.00
1.1
1.3
u/l
59.6
58.8
—
7
23
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
92
1.66
0.98
2.9
1.4
u/l
12.2
7.8
0.57
15
78
(3050129) First trimester maternal screen panel - Serum or Plasma
8
143
0.55
0.95
1.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
87
1.63
0.88
1.6
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
87
1.63
0.88
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
87
1.63
0.88
1.6
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
103
893
1.21
0.87
4.3
2.8
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
30
2.01
0.87
1.3
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
202
0.63
0.85
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
46
1.75
0.83
1.8
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
32
1.89
0.82
2.5
1.7
—
—
—
0
0
(44813793)
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
25
0.00
0.79
0.0
1.5
—
91.1
—
0
25
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
412
0.76
0.77
2.0
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.76
2.0
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
34
1.78
0.76
2.3
2.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
24
2.10
0.74
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
24
2.10
0.74
1.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
109
1.49
0.72
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
2.4
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
145
0.61
0.71
1.3
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
27
1.86
0.68
1.2
1.8
mmol/l
7.5
6.7
—
5
15
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
43
1.64
0.67
3.9
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
70
1.59
0.66
1.4
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
127
0.62
0.65
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
127
0.62
0.65
1.3
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.8
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
29
1.73
0.64
2.2
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
3.0
2.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
52
1.55
0.60
2.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
89
1.48
0.58
1.4
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
36
1.68
0.57
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
126
0.63
0.55
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
126
0.63
0.55
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
38
1.59
0.54
3.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
73
824
0.86
0.53
4.7
3.4
estimate
0.0
0.0
0.88
25
284
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
3.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
3.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
3.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
39
1.55
0.53
3.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
134
0.66
0.52
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
3.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
19
144
1.34
0.51
1.0
1.1
—
232.0
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
47
400
1.20
0.51
1.6
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
47
1.50
0.48
1.4
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
47
1.50
0.48
3.6
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
121
0.65
0.46
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
285
0.80
0.45
1.9
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
31
1.62
0.43
1.4
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
286
1.21
0.43
2.6
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.2
nmol/l
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
343
1.18
0.42
5.1
3.8
%
34.4
31.6
0.68
25
237
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
16
0.00
0.41
0.0
1.0
—
391.8
—
0
16
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
70
630
1.13
0.40
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
102
0.68
0.40
1.3
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
1.7
—
0
7
(3003740) Influenza virus B Ag [Presence] in Specimen
9
70
1.29
0.37
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
70
1.29
0.37
1.2
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
238
1.19
0.33
2.0
2.3
ml/min/173m2
89.9
69.8
—
8
87
(40768800) Prostate Pathology biopsy report
6
46
1.31
0.33
1.5
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
92
1.31
0.32
1.4
1.9
iu/l
3.2
5.5
—
6
31
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
52
1.35
0.31
1.6
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
98
0.71
0.31
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
99
0.70
0.31
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
175
1.21
0.31
2.4
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
83
771
1.10
0.29
6.0
4.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
215
0.83
0.28
4.6
3.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
115
1.23
0.24
2.1
1.7
nmol/l
42.9
37.8
0.28
14
115
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
128
1225
1.07
0.22
4.1
3.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
18.8
—
0
12
(3041806) Other cells [#/volume] in Blood by Manual count
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
7.6
—
0
13
(40765096) Chromosome analysis panel by Banding
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
53
1.13
0.18
3.7
2.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
68
0.73
0.17
2.2
3.9
mmol/l
3.4
3.8
—
5
63
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
327
0.91
0.15
5.6
5.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
80
1.13
0.15
1.9
1.9
pmol/l
200.8
196.1
—
9
75
(40768793) Breast Pathology biopsy report
7
89
0.78
0.14
1.0
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.10
1.4
1.4
u/l
11.6
26.1
—
5
38
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
55
1.09
0.09
5.3
3.6
e9/l
3.2
3.9
—
6
55
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
58
1.04
0.08
5.3
3.7
%
54.2
57.2
—
6
58
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
61
0.82
0.08
1.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
1.2
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
74
1.08
0.07
1.8
1.8
—
—
—
0
0
(4094501)
10
89
1.13
0.07
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
227
1.06
0.06
1.9
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
130
1.08
0.04
2.0
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
49
1.02
0.00
1.4
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.4
—
3.6
—
0
9
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
79
1.01
0.00
2.0
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
14.3
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_TEETH_HARD_NOS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_TEETH_HARD_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_TEETH_HARD_NOS – Disease of hard tissues of teeth, NOS
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data